Bleakley Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Sell |
66,081
-4,637
| -7% | -$320K | 0.12% | 157 |
|
|
2025
Q1 | $4.91M | Buy |
70,718
+625
| +0.9% | +$43.4K | 0.16% | 127 |
|
|
2024
Q4 | $6.03M | Sell |
70,093
-9,086
| -11% | -$782K | 0.18% | 94 |
|
|
2024
Q3 | $9.43M | Sell |
79,179
-41,828
| -35% | -$4.98M | 0.29% | 56 |
|
|
2024
Q2 | $17.3M | Sell |
121,007
-31,086
| -20% | -$4.44M | 0.5% | 34 |
|
|
2024
Q1 | $19.5M | Buy |
152,093
+28,222
| +23% | +$3.62M | 0.57% | 28 |
|
|
2023
Q4 | $12.8M | Buy |
123,871
+2,769
| +2% | +$286K | 0.41% | 44 |
|
|
2023
Q3 | $11M | Buy |
121,102
+51,952
| +75% | +$4.72M | 0.39% | 51 |
|
|
2023
Q2 | $5.6M | Buy |
69,150
+5,490
| +9% | +$444K | 0.17% | 109 |
|
|
2023
Q1 | $5.07M | Buy |
63,660
+11,928
| +23% | +$949K | 0.17% | 109 |
|
|
2022
Q4 | $3.5M | Buy |
+51,732
| New | +$3.5M | 0.13% | 157 |
|